AgraFlora Organics International's wholly-owned subsidiary Sustainable Growth Strategic Capital (“SGSC”) has received Health Canada approval to commence extraction at its licensed facility pursuant to an amendment to its Standard Processing License. SGSC also holds Standard Cultivation and Medical Sales Licenses issued pursuant to the Cannabis Act.
"{SGSC has been actively engaged in the Canadian CBD business working with partner farmers to optimize the harvest to hemp-crops to maximize the efficiency of subsequent CBD extraction," the team with the company explains. "In March SGSC commenced a trial extraction of hemp-biomass which will be extracted using third-party extraction services and sold as a combination of CBD Crude Oil CBD Distillate and CBD Isolate to Canadian purchasers. If the Trial yields favourable results with respect to product quality efficiency and margin SGSC intends to move quickly with a second production cycle of up to 1300 KG of high-quality hemp biomass containing CBD concentrations over 8%.
"The current SGSC facility is designed to facility up to 250000 kg of biomass extraction capacity utilizing chilled ethanol for primary extraction followed by distillation and/or isolation. SGSC intends to use the Trial and subsequent third party extraction cycles to properly design and size its in-house extraction capacity to maximize the profitability and return on capital invested. Once built SGSC intends to improve its profitability by reducing the cost of extraction purification and fulfilment by bringing those processes in-house."
For more information:
AgraFlora Organics
agraflora.com